release time:2021-08-12 15:28:01

For patients with acute cardiac infarction, the application of the cTnl point-of-care diagnostic reagent, a marker of myocardial injury, makes it easier and more accurate to diagnose and determine the treatment plan for such acute patients, if the clinical presentation is highly suspicious and the ECG presentation is not conclusive. The best part is that the entire diagnostic process takes only 15 minutes.
2026-01-12
In the rapidly evolving field of Point-of-Care Testing (POCT), the debate between CLIA vs. FIA is central to clinical efficiency. While both are pillars of immunoassay diagnostics, they differ significantly in sensitivity, background interference, and diagnostic range. This 2026 guide breaks down these technologies to help clinics choose the best path for high-precision testing.
2022-02-24
Although the tests were done at the same time, the two results differed greatly. Which is more accurate, the blood glucose meter or the biochemistry analyzer?
2021-08-23
The performance of in vitro diagnostic reagents is mainly reflected in three aspects.1. Analytical performance: It mainly includes precision, accuracy, sensitivity, specificity, linear range and other performance of reagents.2、Diagnostic performance: the sensitivity and specificity of the detected substances.3、Stability: the validity period, transportation stability, open bottle stability, and accelerated stability of reagents.